Icon

LIALDA (nda022000)- (1.2GM)

MESALAMINE TAKEDA PHARMS USA
1.2GM
Yes No
2020-Jun-08 Expired
None None
None No
LIALDA is an aminosalicylate indicated for the: • induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. • treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
6 0 5
Total Other Developers 36
Drugs with Suitability No
1.2GM ** ** Down - 5
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** *** ***** *** ************** ********** ******* *** *********** *-* & *-*, **** ********** ****, **********, *********** ******, ***** (***) ***
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** **************** *** ****** ****** ***. *********** **.***, ****** **, ******** ******, ****** ********, *******, ******* ******, ***** (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.